未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer
Loughman, Tony; Barron, Stephen; Wang, Chan-Ju Angel; Dynoodt, Peter; Fender, Bozena; Lopez-Ruiz, Cesar; Stapleton, Sharon; Fabre, Aurelie; Quinn, Cecily; Nodin, Bjorn; Jirstrom, Karin; Razmara, Fatemeh; O'Grady, Anthony; Baird, Anne-Marie; Gray, Steven G.; Freixo, Ana; Moelans, Cathy B.; van Diest, Paul J.; Duffy, Michael J.; O'Leary, Desmond; Crown, John; Bracken, Adrian P.; Gallagher, William M.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Targeting c-Met in triple negative breast cancer: preclinical studies using the c-Met inhibitor, Cpd A在三阴性乳腺癌中靶向c-met: 使用c-met抑制剂Cpd的临床前研究
Breen, Laura; Gaule, Patricia B.; Canonici, Alexandra; Walsh, Naomi; Collins, Denis M.; Cremona, Mattia; Hennessy, Bryan T.; Duffy, Michael J.; Crown, John; O' Donovan, Norma; Eustace, Alex J.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007
Synnott, Naoise C.; Bauer, Matthias R.; Madden, Stephen; Murray, Alyson; Klinger, Rut; O'Donovan, Norma; O'Connor, Darran; Gallagher, William M.; Crown, John; Fersht, Alan R.; Duffy, Michael J.
分享
收藏
分享
收藏